Reuters: Merck bets on generic biotech in strategic shift

[chris]

Merck bets on generic biotech in strategic shift
      

WHITEHOUSE STATION, New Jersey (Reuters) - Merck &amp; Co  plans to break into biotechnology medicine, including a major push into the developing market for generic biotech, as it confronts challenges to its product line.<div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login